Judith Hahn, PhD, MA

Professor

I am a Professor in Residence in the HIV, ID, and Global Medicine Division in the Department of Medicine.

Substance use plays important biological and behavioral roles in health outcomes, and my work consists of epidemiology at the intersection of substance use and infectious diseases. My research team is currently conducting several NIH-funded studies to examine the use of TB prophylaxis in HIV/TB co-infected alcohol users, as well as interventions to reduce drinking and increase antiretroviral therapy adherence. We are using novel biomarkers of alcohol consumption and INH pill-taking to gain objective measurements where self-report is problematic. I am also teaching and mentoring via a K-24 award, and grant-writing courses in Epidemiology and Biostatistics and the UCSF CTSI KL2 Scholars Program.
Education
2019 - Diversity, Equity, and Inclusion Champion Training, University of California
PhD, 05/2001 - Epidemiology, University of California, Berkeley
MA, 05/1990 - Biostatistics, University of California, Berkeley
BS, 06/1987 - Statistics and Biometry, Cornell University
Websites
Publications

  1. Hahn JA, Kane JC, Fatch R, Espinosa da Silva C, Emenyonu NI, Scheffler A, Chirayil P, So-Armah K, Kahler CW, Conroy AA, Edelman EJ, Woolf-King S, Parry CD, Kiene SM, Chamie G, Muyindike WR, Adong J, Go VF, Cook RL, Morojele NK, Fiellin DA, Santos GM, Tahir P, Samet J, Krupitsky E, Allen IE. Alcohol interventions for persons with HIV: Meta-analysis of randomized controlled trials using phosphatidylethanol and self-report. 2025. PMID: 40992009


  2. Kiene SM, Miller AP, Ediau M, Tuhebwe D, Sileo KM, Naigino R, Hahn JA, Reed E, Anecho A, Mukasa B, Lin CD, Wanyenze RK, Tumwesigye NM. A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high-risk alcohol use and improve antiretroviral therapy adherence for men in Uganda. 2025. PMID: 40887734


  3. Kane JC, Chirayil P, Pawar R, Inoue S, Hofer T, McDonell M, Latkin C, Chander G, Martins SS, Greene MC, Vinikoor M, Sharma A, Hahn JA. Measuring alcohol consumption with biomarkers in intervention studies: A scoping review. 2025. PMID: 40801459


  5. Conroy AA, Butterfield RM, Chibi B, Hahn JA, Neilands TB, Msimango L, van Heerden A, Humphries H, Starks TJ. Pilot Results of Masibambisane: Couples Motivational Interviewing with Mobile Breathalyzers to Address Unhealthy Drinking and Adherence to Antiretroviral Therapy in South Africa. 2025. PMID: 40551071


  6. Odokonyero RF, Muhwezi WW, Musanje K, Sanyu N, Muyindike WR, Katahoire AR, Camlin CS, Hahn JA, Nakasujja N. The Lived Experiences of Unhealthy Alcohol Use among Young People with HIV in Southwestern Uganda. 2025. PMID: 40439766


  7. Lancaster KE, Bula AK, Matoga MM, Hosseinipour MC, Hoffman IF, Grullon JA, Umar E, Msolola J, Magidson JF, Bonumwezi JL, Hahn JA, Parcesepe AM. Testing a systematically braided alcohol reduction and HIV status neutral intervention among people receiving STI care in Malawi: study protocol for a pilot hybrid type 1 effectiveness-implementation randomized controlled trial. 2025. PMID: 40371302


  8. Castle AC, Busang J, Dreyer J, Herbst C, Okesola N, Chimbindi N, Zuma T, Jarolimova J, Hahn JA, Psaros C, Shenoi SV, Shahmanesh M, Siedner MJ. Alcohol Use and the Pre-exposure Prophylaxis Continuum of Care Among Men in Rural South Africa: Results from a Longitudinal Study. 2025. PMID: 40185960


  9. Abbott R, Landsiedel K, Atukunda M, Puryear SB, Chamie G, Hahn JA, Mwangwa F, Kakande E, Petersen ML, Havlir DV, Charlebois E, Balzer LB, Kamya MR, Marquez C. Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda. 2024. PMID: 38824440


  10. Mkandawire J, Ssewamala FM, Hahn JA, Mulauzi N, Neilands TB, Tebbetts S, Darbes LA, Brown DS, Conroy AA. Economic and relationship-strengthening intervention to reduce alcohol use in couples living with HIV in Malawi: a study protocol for a randomised controlled trial of Mlambe. 2025. PMID: 39929508


  11. Muyindike WR, Fatch R, Lodi S, Emenyonu NI, Kekibiina A, Adong J, Beesiga B, Marson K, Thirumurthy H, McDonell MG, Kamya MR, Chamie G, Hahn JA. Alcohol use and HIV suppression after completion of financial incentives for alcohol abstinence and isoniazid adherence: a randomized controlled trial. 2025. PMID: 39867970


  12. Hahn JA, Piano MR, Hwang CL, Justice AC. Phosphatidylethanol Can Improve Detection and Treatment of Unhealthy Alcohol Use. 2024. PMID: 39547265


  13. Murnane PM, Afshar M, Chamie G, Cook RL, Ferguson T, Haque LY, Jacobson KR, Justice AC, Kim TW, Khalili M, Krupitsky E, McGinnis KA, Molina P, Muyindike WR, Myers B, Richards VL, So-Armah K, Stewart S, Sulkowski MS, Tien PC, Hahn JA. Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk. 2024. PMID: 39480054


  14. Conroy AA, Ruark A, Mulauzi N, Mkandawire J, Darbes LA, Hahn JA, Neilands TB, Tebbetts S, Ssewamala FM. Mlambe economic and relationship-strengthening intervention for alcohol use decreases violence and improves relationship quality in couples living with HIV in Malawi. 2024. PMID: 39405663


  15. Jain JP, Ma Y, Dawson-Rose C, Santos GM, Han A, Price J, Hahn JA, Tien PC. The prevalence and correlates of biomarker positive unhealthy alcohol use among women living with and without HIV in San Francisco, California. 2024. PMID: 39365789


  16. Odokonyero RF, Nakasujja N, Turiho A, Sanyu N, Muyindike WR, Nansera D, Semitala F, Kamya MR, Katahoire AR, Hahn JA, Camlin CC, Muhwezi WW. Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study. 2024. PMID: 39223677


  17. Savinkina A, Muyindike W, Hahn JA, Emenyonu NI, Fatch R, Ngabirano C, Adong J, Jacobson KR, Linas BP. Strategies for isoniazid preventive therapy in HIV-positive patients who consume alcohol. 2024. PMID: 38961548


  18. Espinosa da Silva C, Fatch R, Emenyonu N, Muyindike W, Adong J, Rao SR, Chamie G, Ngabirano C, Tumwegamire A, Kekibiina A, Marson K, Beesiga B, Sanyu N, Katusiime A, Hahn JA. Psychometric assessment of the Runyankole-translated Marlowe-Crowne Social Desirability Scale among persons with HIV in Uganda. 2024. PMID: 38898463


  20. Appa A, Miller AP, Fatch R, Kekibiina A, Beesiga B, Adong J, Emenyonu N, Marson K, Getahun M, Kamya M, Muyindike W, McDonell M, Thirumurthy H, Hahn JA, Chamie G, Camlin CS. Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: A qualitative study. 2024. PMID: 38656992


  21. Conroy AA, Hahn JA, Neilands TB, Darbes LA, Tebbetts S, Mulauzi N, Mkandawire J, Ssewamala FM. Pilot Trial Results of Mlambe: An Economic and Relationship-Strengthening Intervention to Address Heavy Drinking and Adherence to Antiretroviral Therapy in Malawi. 2024. PMID: 38551718


  22. Tumwegamire A, Fatch R, Emenyonu NI, Lodi S, Muyindike WR, Kekibiina A, Adong J, Ngabirano C, Beesiga B, Marson K, Golabi N, Kamya M, Chamie G, Hahn JA. Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda. 2024. PMID: 38507431


  23. Msimango L, Butterfield R, Starks TJ, van Heerden A, Neilands TB, Hahn JA, Chibi B, Humphries H, Conroy AA. Couples motivational interviewing with mobile breathalysers to reduce alcohol use in South Africa: a pilot randomised controlled trial of Masibambisane. 2024. PMID: 38296300


  24. Miller AP, Appa A, Muyindike W, Fatch R, Kekibiina A, Beesiga B, Adong J, Emenyonu N, Marson K, Getahun M, Kamya M, Chamie G, Camlin CS, Hahn JA. A Qualitative Exploration of Intimate Partner Violence Among HIV/TB Coinfected Persons With Problematic Alcohol Use Participating in an Incentive-Based Alcohol/Medication Adherence Intervention in Uganda During COVID-19. 2024. PMID: 38196278


  25. Odokonyero RF, Fatch R, Emenyonu NI, Cheng DM, Ngabirano C, Adong J, Muyindike WR, Nakasujja N, Camlin CS, Kamya M, Hahn JA. The Relationship between Age at Initiation of Regular Drinking of Alcohol and Viral Suppression Status, and Depression Symptoms Among People Living with HIV in South-Western Uganda. 2023. PMID: 38060110


  26. Puryear SB, Mwangwa F, Opel F, Chamie G, Balzer LB, Kabami J, Ayieko J, Owaraganise A, Kakande E, Agengo G, Bukusi E, Kabageni S, Omoding D, Bacon M, Schrom J, Woolf-King S, Petersen ML, Havlir DV, Kamya M, Hahn JA. Effect of a brief alcohol counselling intervention on HIV viral suppression and alcohol use among persons with HIV and unhealthy alcohol use in Uganda and Kenya: a randomized controlled trial. 2023. PMID: 38054564


  27. Chamie G, Hahn JA, Kekibiina A, Emenyonu NI, Beesiga B, Marson K, Fatch R, Lodi S, Adong J, Thirumurthy H, McDonell MG, Gandhi M, Bryant K, Havlir DV, Kamya MR, Muyindike WR. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial. 2023. PMID: 37973340


  28. von Witzleben M, Hahn J, Richter RF, de Freitas B, Steyer E, Schütz K, Vater C, Bernhardt A, Elschner C, Gelinsky M. Tailoring the pore design of embroidered structures by melt electrowriting to enhance the cell alignment in scaffold-based tendon reconstruction. 2023. PMID: 38029698


  29. Tierney HR, Ma Y, Bacchetti P, Adimora AA, Chandran A, Kempf MC, Collins LF, DeHovitz J, DiClemente RJ, French AL, Jones DL, Sharma A, Spence AB, Hahn JA, Price JC, Tien PC. Pivoting from in-person to phone survey assessment of alcohol and substance use: effects on representativeness in a United States prospective cohort of women living with and without HIV. 2023. PMID: 37956200


  30. Naigino R, Miller AP, Ediau M, Anecho A, Senoga U, Tumwesigye NM, Wanyenze RK, Mukasa B, Hahn JA, Reed E, Sileo KM, Kiene SM. Stakeholder perspectives on the Kisoboka intervention: A behavioral and structural intervention to reduce hazardous alcohol use and improve HIV care engagement among men living with HIV in Ugandan fishing communities. 2023. PMID: 37952352


  31. McLaughlin A, Lin N, Jiang W, Lodi S, Lioznov D, Patts G, Gnatienko N, Blokhina E, Bendiks S, Freiberg MS, Tindle HA, Krupitsky E, Hahn JA, Samet JH, So-Armah K. Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia. 2023. PMID: 37850982


  32. Adong J, Musinguzi N, Ngonzi J, Haberer JE, Bassett IV, Siedner MJ, Roberts DJ, Hahn JA, Bebell LM. Effects of Maternal HIV Infection and Alcohol Use in Pregnancy on Birth Outcomes in Uganda. 2023. PMID: 37843685


  34. Puryear SB, Ayieko J, Hahn JA, Mucunguzi A, Owaraganise A, Schwab J, Balzer LB, Kwarisiima D, Charlebois ED, Cohen CR, Bukusi EA, Petersen ML, Havlir DV, Kamya MR, Chamie G. Universal HIV Testing and Treatment with Patient-Centered Care Improves ART Uptake and Viral Suppression among Adults Reporting Hazardous Alcohol Use in Uganda and Kenya. 2023. PMID: 37220015


  35. Gichane MW, Camlin CS, Getahun M, Emenyonu N, Woolf-King S, Sanyu N, Katusiime A, Fatch R, Muyindike W, Hahn JA. Understanding Patients' Experiences with a Brief Alcohol Reduction Intervention among People Living with HIV in Uganda: A Qualitative Study. 2023. PMID: 37551890


  36. Parry CDH, Myers B, Londani M, Shuper PA, Janse van Rensburg C, Manda SOM, Nkosi S, Kekwaletswe CT, Hahn JA, Rehm J, Sorsdahl K, Morojele NK. Motivational interviewing and problem-solving therapy intervention for patients on antiretroviral therapy for HIV in Tshwane, South Africa: A randomized controlled trial to assess the impact on alcohol consumption. 2023. PMID: 37339811


  37. Kane JC, Mauro PM, Hahn JA, Chander G, Tobin KE, Martins SS, Paniagua-Avila A, Latkin CA. HIV stigma and disclosure of alcohol use to physicians: examining the mediating role of depression among persons living with HIV. 2023. PMID: 37314960


  38. Kane JC, Allen I, Fatch R, Scheffler A, Emenyonu N, Puryear SB, Chirayil P, So-Armah K, Kahler CW, Magidson JF, Conroy AA, Edelman EJ, Woolf-King S, Parry C, Kiene SM, Chamie G, Adong J, Go VF, Cook RL, Muyindike W, Morojele N, Blokhina E, Krupitsky E, Fiellin DA, Hahn JA. Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis. 2023. PMID: 37280036


  39. Hahn JA, Ngabirano C, Fatch R, Emenyonu NI, Cheng DM, Adong J, Tumwegamire A, Terrault NA, Linas BP, Jacobson KR, Muyindike WR. Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use: a single arm trial. 2023. PMID: 37260251


  40. Beesiga B, Marson K, Fatch R, Emenyonu NI, Adong J, Kekibiina A, Puryear S, Lodi S, McDonell MG, Muyindike WR, Kamya MR, Hahn JA, Chamie G. Effects of a COVID-19 Public Health Lockdown on Drinking and Health Behavior Among Persons with HIV and with Unhealthy Alcohol use in Uganda. 2023. PMID: 37000383


  41. Firkey MK, Tully LK, Bucci VM, Walsh ME, Maisto SA, Hahn JA, Bendinskas KG, Gump BB, Woolf-King SE. Feasibility of remote self-collection of dried blood spots, hair, and nails among people with HIV with hazardous alcohol use. 2023. PMID: 36949025


  42. Parry CDH, Myers B, Londani M, Shuper PA, Nkosi S, Hahn JA, Kekwaletswe C, Morojele NK. Self-reported alcohol use versus phosphatidylethanol in behavioral trials: A study of people living with HIV in Tshwane, South Africa. 2023. PMID: 36940726


  44. Bertholet N, Saitz R, Hahn JA, Heeren TC, Emenyonu NI, Freiberg M, Winter MR, Kim TW, Magane K, Lloyd-Travaglini C, Fatch R, Bryant K, Forman LS, Rateau L, Blokhina E, Muyindike WR, Gnatienko N, Samet JH. Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV. 2023. PMID: 36799302


  47. Stanton AM, Hornstein BD, Musinguzi N, Dolotina B, Orrell C, Amanyire G, Asiimwe S, Cross A, Psaros C, Bangsberg D, Hahn JA, Haberer JE, Matthews LT, META Study Team. Factors Associated With Changes in Alcohol Use During Pregnancy and the Postpartum Transition Among People With HIV in South Africa and Uganda. 2023. PMID: 36945860


  48. Conroy AA, Tebbetts S, Darbes LA, Hahn JA, Neilands TB, McKenna SA, Mulauzi N, Mkandawire J, Ssewamala FM. Development of an Economic and Relationship-Strengthening Intervention for Alcohol Drinkers Living with HIV in Malawi. 2022. PMID: 36520335


  49. Muyindike WR, Fatch R, Cheng DM, Emenyonu NI, Forman L, Ngabirano C, Adong J, Linas B, Jacobson KR, Hahn JA. Unhealthy Alcohol Use is Associated with sub-Optimal Adherence to Isoniazid Preventive Therapy in Persons with HIV in southwestern Uganda. 2022. PMID: 36044285


  50. Asiimwe C, Fatch R, Cheng DM, Emenyonu NI, Ngabirano C, Muyindike WR, Hahn JA. Bar Attendance and Alcohol Use Before and After COVID-19 Related Restrictions Among HIV-infected Adults in South-Western Uganda. 2022. PMID: 36441412


  51. Miller AP, Fatch R, Lodi S, Marson K, Emenyonu N, Kekibiina A, Beesiga B, Chamie G, Muyindike WR, Hahn JA. Unhealthy alcohol use and intimate partner violence among men and women living with HIV in Uganda. 2022. PMID: 36217183


  52. Forman LS, Lodi S, Fatch R, Emenyonu NI, Adong J, Ngabirano C, Jacobson KR, Gerona R, Reckers AR, Gandhi M, Muyindike WR, Hahn JA. Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in Uganda. 2022. PMID: 36320196


  56. Kim TW, Heeren TC, Samet JH, Bertholet N, Lloyd-Travaglini C, Winter MR, Magane KM, Gnatienko N, Bryant K, Rateau LJ, Muyindike WR, Hahn JA, Blokhina E, Saitz R. Alcohol and falls among people with HIV infection: A view from Russia and the United States. 2022. PMID: 35957545


  57. Tindle HA, Freiberg MS, Cheng DM, Gnatienko N, Blokhina E, Yaroslavtseva T, Bendiks S, Patts G, Hahn J, So-Armah K, Stein MD, Bryant K, Lioznov D, Krupitsky E, Samet JH. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial. 2022. PMID: 35930287


  58. Belus JM, Joska JA, Bronsteyn Y, Rose AL, Andersen LS, Regenauer KS, Myers B, Hahn JA, Orrell C, Safren SA, Magidson JF. Gender Moderates Results of a Randomized Clinical Trial for the Khanya Intervention for Substance Use and ART Adherence in HIV Care in South Africa. 2022. PMID: 35895150


  59. Hirchak KA, Amiri S, Kordas G, Oluwoye O, Lyons AJ, Bajet K, Hahn JA, McDonell MG, Campbell ANC, Venner K. Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes. 2022. PMID: 35614487


  61. Tully DC, Hahn JA, Bean DJ, Evans JL, Morris MD, Page K, Allen TM. Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships. 2021. PMID: 34448809


  62. Woolf-King SE, Firkey M, Foley JD, Bricker J, Hahn JA, Asiago-Reddy E, Wikier J, Moskal D, Sheinfil AZ, Ramos J, Maisto SA. Development of a Telephone-Delivered Acceptance and Commitment Therapy Intervention for People Living with HIV who are Hazardous Drinkers. 2022. PMID: 35303190


  63. Pierre F, Forman LS, Winter M, Cheng D, Ngabirano C, Emenyonu N, Hunt PW, Huang Y, Muyindike W, Samet J, Hahn JA, So-Armah K. Alcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation: The Uganda ARCH Cohort Study. 2021. PMID: 34027552


  64. Alcover KC, Emenyonu NI, Fatch R, Kekibiina A, Marson K, Chamie G, Muyindike WR, Beesiga B, Kamya MR, Lodi S, Kane JC, Hahn JA, McDonell MG. Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda. 2022. PMID: 35103888


  65. Ngabirano C, Fatch R, Muyindike WR, Emenyonu NI, Adong J, Weiser SD, Samet JH, Cheng DM, Hahn JA. Exploring the Association Between Social Support and Hazardous Alcohol Use Among Persons Living with HIV in South Western Uganda. 2022. PMID: 35039935


  66. Fatch R, Luginbühl M, Cheng DM, Gaugler S, Emenyonu NI, Ngabirano C, Adong J, Muyindike WR, Samet JH, Bryant K, Hahn JA. Comparison of automated determination of phosphatidylethanol (PEth) in dried blood spots (DBS) with previous manual processing and testing. 2021. PMID: 34767948


  67. Mutumba M, Woolf-King S, Carrico AW, Emenyonu NI, Fatch R, Kekibiina A, Muyindike W, Hahn JA. Correlates and Effects of Alcohol Use Expectancies Among Persons Living with HIV in Uganda. 2021. PMID: 34599420


  68. Kekibiina A, Adong J, Fatch R, Emenyonu NI, Marson K, Beesiga B, Lodi S, Muyindike WR, Kamya M, Chamie G, McDonell MG, Hahn JA. Post-traumatic stress disorder among persons with HIV who engage in heavy alcohol consumption in southwestern Uganda. 2021. PMID: 34535103


  69. Sheira LA, Frongillo EA, Hahn J, Palar K, Riley ED, Wilson TE, Adedimeji A, Merenstein D, Cohen M, Wentz EL, Adimora AA, Ofotokun I, Metsch L, Turan JM, Tien PC, Weiser SD. Relationship between food insecurity and smoking status among women living with and at risk for HIV in the USA: a cohort study. 2021. PMID: 34489299


  70. Marcus GM, Vittinghoff E, Whitman IR, Joyce S, Yang V, Nah G, Gerstenfeld EP, Moss JD, Lee RJ, Lee BK, Tseng ZH, Vedantham V, Olgin JE, Scheinman MM, Hsia H, Gladstone R, Fan S, Lee E, Fang C, Ogomori K, Fatch R, Hahn JA. Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events. 2021. PMID: 34461028


  72. Perkins JM, Kakuhikire B, Baguma C, Jurinsky J, Rasmussen JD, Satinsky EN, Namara E, Ahereza P, Kyokunda V, Perkins HW, Hahn JA, Bangsberg DR, Tsai AC. Overestimation of alcohol consumption norms as a driver of alcohol consumption: a whole-population network study of men across eight villages in rural, southwestern Uganda. 2021. PMID: 34159646


  73. Gnatienko N, Calver K, Sullivan M, Forman LS, Heeren T, Blokhina E, Emenyonu N, Ventura AS, Tsui JI, Muyindike WR, Fatch R, Ngabirano C, Bridden C, Bryant K, Bazzi AR, Hahn JA. Heavy Alcohol Use Among Women and Men Living With HIV in Uganda, Russia, and the United States. 2021. PMID: 34343080


  74. Freiman JM, Fatch R, Cheng D, Emenyonu N, Ngabirano C, Geadas C, Adong J, Muyindike WR, Linas BP, Jacobson KR, Hahn JA. Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda. 2021. PMID: 34061870


  75. Lodi S, Emenyonu NI, Marson K, Kwarisiima D, Fatch R, McDonell MG, Cheng DM, Thirumurthy H, Gandhi M, Camlin CS, Muyindike WR, Hahn JA, Chamie G. The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial. 2021. PMID: 34016158


  76. Hahn JA, Murnane PM, Vittinghoff E, Muyindike WR, Emenyonu NI, Fatch R, Chamie G, Haberer JE, Francis JM, Kapiga S, Jacobson K, Myers B, Couture MC, DiClemente RJ, Brown JL, So-Armah K, Sulkowski M, Marcus GM, Woolf-King S, Cook RL, Richards VL, Molina P, Ferguson T, Welsh D, Piano MR, Phillips SA, Stewart S, Afshar M, Page K, McGinnis K, Fiellin DA, Justice AC, Bryant K, Saitz R. Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis. 2021. PMID: 33837975


  77. Aschbacher K, Hendershot CS, Tison G, Hahn JA, Avram R, Olgin JE, Marcus GM. Machine learning prediction of blood alcohol concentration: a digital signature of smart-breathalyzer behavior. 2021. PMID: 33879844


  78. Puryear SB, Fatch R, Beesiga B, Kekibiina A, Lodi S, Marson K, Emenyonu NI, Muyindike WR, Kwarisiima D, Hahn JA, Chamie G. Higher levels of alcohol use are associated with latent tuberculosis infection in adults living with HIV. 2020. PMID: 32374867


  79. Leddy AM, Hahn JA, Getahun M, Emenyonu NI, Woolf-King SE, Sanyu N, Katusiime A, Fatch R, Chander G, Hutton HE, Muyindike WR, Camlin CS. Cultural Adaptation of an Intervention to Reduce Hazardous Alcohol Use Among People Living with HIV in Southwestern Uganda. 2021. PMID: 33590322


  80. Metcalfe J, Bacchetti P, Esmail A, Reckers A, Aguilar D, Wen A, Huo S, Muyindike WR, Hahn JA, Dheda K, Gandhi M, Gerona R. Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting. 2021. PMID: 33482745


  82. Wagman JA, Nabukalu D, Miller AP, Wawer MJ, Ssekubugu R, Nakowooya H, Nantume B, Park E, Hahn JA, Serwadda DM, Sewankambo NK, Nalugoda F, Kigozi G. Prevalence and correlates of men's and women's alcohol use in agrarian, trading and fishing communities in Rakai, Uganda. 2020. PMID: 33125397


  83. Muyindike WR, Fatch R, Cheng DM, Emenyonu NI, Ngabirano C, Adong J, Linas BP, Jacobson KR, Hahn JA. Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda. 2020. PMID: 32614873


  84. Foley JD, Sheinfil A, Woolf-King SE, Fatch R, Emenyonu NI, Muyindike WR, Kekibiina A, Ngabirano C, Samet JH, Cheng DM, Hahn JA. Assessing the interaction between depressive symptoms and alcohol use prior to antiretroviral therapy on viral suppression among people living with HIV in Rural Uganda. 2020. PMID: 32482097


  85. Conroy AA, Ruark A, McKenna SA, Tan JY, Darbes LA, Hahn JA, Mkandawire J. The Unaddressed Needs of Alcohol-Using Couples on Antiretroviral Therapy in Malawi: Formative Research on Multilevel Interventions. 2019. PMID: 31456201


  87. Puryear SB, Balzer LB, Ayieko J, Kwarisiima D, Hahn JA, Charlebois ED, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV, Chamie G. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. 2019. PMID: 31725431


  88. Raggio GA, Psaros C, Fatch R, Goodman G, Matthews LT, Magidson JF, Amanyire G, Cross A, Asiimwe S, Hahn JA, Haberer JE. High Rates of Biomarker-Confirmed Alcohol Use among Pregnant Women Living with HIV in South Africa and Uganda. 2019. PMID: 31567551


  90. Adong J, Fatch R, Emenyonu NI, Cheng DM, Muyindike WR, Ngabirano C, Kekibiina A, Woolf-King SE, Samet JH, Hahn JA. Social desirability bias impacts self-reported alcohol use among persons with HIV in Uganda. 2019. PMID: 31610017


  91. Hahn J, Schulze-Tanzil G, Schröpfer M, Meyer M, Gögele C, Hoyer M, Spickenheuer A, Heinrich G, Breier A. Viscoelastic Behavior of Embroidered Scaffolds for ACL Tissue Engineering Made of PLA and P(LA-CL) After In Vitro Degradation. 2019. PMID: 31546928


  92. Magidson JF, Fatch R, Orrell C, Amanyire G, Haberer JE, Hahn JA. Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa. 2018. PMID: 30560484


  93. Hahn JA, Tully DC, Evans JL, Morris MD, Briceno A, Bean DJ, Allen TM, Page K. Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships. 2019. PMID: 31041340


  94. Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. 2019. PMID: 30921649


  95. Adong J, Lindan C, Fatch R, Emenyonu NI, Muyindike WR, Ngabirano C, Winter MR, Lloyd-Travaglini C, Samet JH, Cheng DM, Hahn JA. The Relationship Between Spirituality/Religiousness and Unhealthy Alcohol Use Among HIV-Infected Adults in Southwestern Uganda. 2018. PMID: 28555316


  96. Hahn JA, Cheng DM, Emenyonu NI, Lloyd-Travaglini C, Fatch R, Shade SB, Ngabirano C, Adong J, Bryant K, Muyindike WR, Samet JH. Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort. Volume 77 of Issue 5. 2018. PMID: 29303844


  97. Mirzazadeh A, Evans JL, Hahn JA, Jain J, Briceno A, Shiboski S, Lum PJ, Bentsen C, Davis G, Shriver K, Dimapasoc M, Stone M, Busch MP, Page K. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. 2018. PMID: 29168067


  98. Freiman JM, Jacobson KR, Muyindike WR, Horsburgh CR, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. 2018. PMID: 29239900


  99. Eyawo O, McGinnis KA, Justice AC, Fiellin DA, Hahn JA, Williams EC, Gordon AJ, Marshall BDL, Kraemer KL, Crystal S, Gaither JR, Edelman EJ, Bryant KJ, Tate JP. Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected. 2018. PMID: 29112041


  100. Coleman SM, Gnatienko N, Lloyd-Travaglini CA, Winter MR, Bridden C, Blokhina E, Lioznov D, Adong J, Samet JH, Liegler T, Hahn JA. False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. 2018. PMID: 29384717


  101. Moore KE, Santiago Rivera OJ, Anderson B, Johnson JE, Hahn JA, Kurth ME, Reddy MK, Schonbrun YC, Stein MD. Phosphatidylethanol Levels Among Incarcerated Women: The Influence of Pre-incarceration Alcohol Consumption and Length of Abstinence. 2018. PMID: 29281858


  102. Woolf-King SE, Fatch R, Cheng DM, Muyindike W, Ngabirano C, Kekibiina A, Emenyonu N, Hahn JA. Alcohol Use and Unprotected Sex Among HIV-Infected Ugandan Adults: Findings from an Event-Level Study. 2018. PMID: 29327090


  103. Morris MD, Montgomery ME, Briceno A, Evans JL, Andrew EVW, Page K, Hahn JA. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners. 2017. PMID: 29286888


  105. Asiimwe SB, Fatch R, Patts G, Winter M, Lloyd-Travaglini C, Emenyonu N, Muyindike W, Kekibiina A, Blokhina E, Gnatienko N, Kruptisky E, Cheng DM, Samet JH, Hahn JA. Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda. 2017. PMID: 28856539


  107. Fatch R, Emenyonu NI, Muyindike W, Kekibiina A, Woolf-King S, Hahn JA. Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda. 2017. PMID: 27198557


  108. Woolf-King SE, Muyindike W, Hobbs MM, Kusasira A, Fatch R, Emenyonu N, Johnson MO, Hahn JA. Vaginal Prostate Specific Antigen (PSA) Is a Useful Biomarker of Semen Exposure Among HIV-Infected Ugandan Women. 2017. PMID: 27224979


  109. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. 2017. PMID: 28362947


  110. Patts GJ, Cheng DM, Emenyonu N, Bridden C, Gnatienko N, Lloyd-Travaglini CA, Ngabirano C, Yaroslavtseva T, Muyindike WR, Weiser SD, Krupitsky EM, Hahn JA, Samet JH. Alcohol Use and Food Insecurity Among People Living with HIV in Mbarara, Uganda and St. Petersburg, Russia. Volume 21 of Issue 3. 2017. PMID: 27699595


  111. Emenyonu NI, Fatch R, Muyindike WR, Kekibiina A, Woolf-King S, Hahn JA. Randomized Study of Assessment Effects on Alcohol Use by Persons With HIV in Rural Uganda. 2017. PMID: 28317511


  112. Kiwanuka N, Ssetaala A, Ssekandi I, Nalutaaya A, Kitandwe PK, Ssempiira J, Bagaya BS, Balyegisawa A, Kaleebu P, Hahn J, Lindan C, Sewankambo NK. Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda. 2017. PMID: 28207844


  113. Muyindike WR, Lloyd-Travaglini C, Fatch R, Emenyonu NI, Adong J, Ngabirano C, Cheng DM, Winter MR, Samet JH, Hahn JA. Phosphatidylethanol confirmed alcohol use among ART-naïve HIV-infected persons who denied consumption in rural Uganda. 2017. PMID: 28278568


  114. Tsui JI, Mirzazadeh A, Hahn JA, Maher L, Bruneau J, Grebely J, Hellard M, Kim AY, Shoukry NH, Cox AL, Prins M, Dore GJ, Lauer G, Lloyd AR, Page K. The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. 2016. PMID: 27816863


  115. Thakarar K, Asiimwe SB, Cheng DM, Forman L, Ngabirano C, Muyindike WR, Emenyonu NI, Samet JH, Hahn JA. Alcohol Consumption in Ugandan HIV-Infected Household-Brewers Versus Non-Brewers. 2016. PMID: 27150894


  117. Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. 2016. PMID: 27696523


  118. Dukes JW, Dewland TA, Vittinghoff E, Olgin JE, Pletcher MJ, Hahn JA, Gladstone RA, Marcus GM. Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws. 2016. PMID: 27301557


  119. Wandera B, Tumwesigye NM, Nankabirwa JI, Mafigiri DK, Parkes-Ratanshi RM, Kapiga S, Hahn J, Sethi AK. Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial. 2016. PMID: 27215561


  121. Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL. Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. 2016. PMID: 26674372


  122. Riley ED, Evans JL, Hahn JA, Briceno A, Davidson PJ, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. 2016. PMID: 26985620


  123. Hahn JA, Emenyonu NI, Fatch R, Muyindike WR, Kekiibina A, Carrico AW, Woolf-King S, Shiboski S. Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report. 2015. PMID: 26381193


  124. Carrico AW, Hunt PW, Emenyonu NI, Muyindike W, Ngabirano C, Cheng DM, Winter MR, Samet JH, Hahn JA. Unhealthy Alcohol Use is Associated with Monocyte Activation Prior to Starting Antiretroviral Therapy. Volume 39 of Issue 12. 2015. PMID: 26509359


  125. Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. More than just someone to inject drugs with: Injecting within primary injection partnerships. 2015. PMID: 26460140


  126. Asiimwe SB, Fatch R, Emenyonu NI, Muyindike WR, Kekibiina A, Santos GM, Greenfield TK, Hahn JA. Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan Africa. 2015. PMID: 26148140


  127. Sundararajan R, Wyatt MA, Woolf-King S, Pisarski EE, Emenyonu N, Muyindike WR, Hahn JA, Ware NC. Qualitative study of changes in alcohol use among HIV-infected adults entering care and treatment for HIV/AIDS in rural southwest Uganda. 2015. PMID: 25323678


  128. Woolf-King SE, Fatch R, Emenyonu N, Muyindike W, Carrico AW, Maisto SA, Hahn JA. Development and validation of the East Africa Alcohol Expectancy Scale (AFEXS). 2015. PMID: 25785809


  130. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn JA. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. Volume 9 of Issue 12. 2014. PMID: 25436894


  132. Parry CD, Morojele NK, Myers BJ, Kekwaletswe CT, Manda SO, Sorsdahl K, Ramjee G, Hahn JA, Rehm J, Shuper PA. Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol. 2014. PMID: 25212696


  133. Hahn JA, Fatch R, Wanyenze RK, Baveewo S, Kamya MR, Bangsberg DR, Coates TJ. Decreases in self-reported alcohol consumption following HIV counseling and testing at Mulago Hospital, Kampala, Uganda. 2014. PMID: 25038830


  135. Kruse GR, Bangsberg DR, Hahn JA, Haberer JE, Hunt PW, Muzoora C, Bennett JP, Martin JN, Rigotti NA. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. Volume 18 of Issue 7. 2014. PMID: 24638166


  139. Santos GM, Emenyonu NI, Bajunirwe F, Rain Mocello A, Martin JN, Vittinghoff E, Bangsberg DR, Hahn JA. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda. 2013. PMID: 24169501


  140. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Szekeres G, Bangsberg DR, Coates T, Hahn JA. Abbreviated HIV counselling and testing and enhanced referral to care in Uganda: a factorial randomised controlled trial. 2013. PMID: 25104262


  142. Fatch R, Bellows B, Bagenda F, Mulogo E, Weiser S, Hahn JA. Alcohol consumption as a barrier to prior HIV testing in a population-based study in rural Uganda. Volume 17 of Issue 5. 2013. PMID: 22878790


  143. Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn JA. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. 2013. PMID: 22744293


  144. Woolf-King SE, Steinmaus CM, Reingold AM, Hahn JA. The International Journal of Drug and Alcohol Research 2013. PMID:


  145. Hahn JA, Fatch R, Kabami J, Mayanja B, Emenyonu NI, Martin J, Bangsberg DR. Self-Report of Alcohol Use Increases When Specimens for Alcohol Biomarkers Are Collected in Persons With HIV in Uganda. 2012. PMID: 23138732


  146. Asher AK, Hahn JA, Couture MC, Maher K, Page K. people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. 2012. PMID: 23164598


  147. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. 2012. PMID: 23090930


  148. Muyindike W, Fatch R, Steinfield R, Matthews LT, Musinguzi N, Emenyonu NI, Martin JN, Hahn JA. Contraceptive use and associated factors among women enrolling into HIV care in southwestern Uganda. 2012. PMID: 23082069


  149. Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. 2012. PMID: 22819868


  151. Baveewo S, Kamya MR, Mayanja-Kizza H, Fatch R, Bangsberg DR, Coates T, Hahn JA, Wanyenze RK. Potential for false positive HIV test results with the serial rapid HIV testing algorithm. 2012. PMID: 22429706


  152. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. 2012. PMID: 22227793


  153. Hahn JA, Dobkin LM, Mayanja B, Emenyonu NI, Kigozi IM, Shiboski S, Bangsberg DR, Gnann H, Weinmann W, Wurst FM. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. 2011. PMID: 22150449


  154. Wurst FM, Thon N, Weinmann W, Tippetts S, Marques P, Hahn JA, Alling C, Aradottir S, Hartmann S, Lakshman R. Characterization of sialic acid index of plasma apolipoprotein J and phosphatidylethanol during alcohol detoxification--a pilot study. 2011. PMID: 21933198


  155. Hahn JA, Woolf-King SE, Muyindike W. Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. 2011. PMID: 21713433


  156. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. 2011. PMID: 21810243


  157. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Sawires S, Bangsberg DR, Coates T, Hahn JA. Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. 2011. PMID: 21750732


  159. Wanyenze RK, Hahn JA, Liechty CA, Ragland K, Ronald A, Mayanja-Kizza H, Coates T, Kamya MR, Bangsberg DR. Linkage to HIV care and survival following inpatient HIV counseling and testing. 2011. PMID: 20431933


  160. Hahn JA, Bwana MB, Javors MA, Martin JN, Emenyonu NI, Bangsberg DR. Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda. 2010. PMID: 20697796


  161. Hahn JA, Samet JH. Alcohol and HIV disease progression: weighing the evidence. 2010. PMID: 20814765


  162. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? 2010. PMID: 20638453


  163. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. 2010. PMID: 20491725


  165. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. 2009. PMID: 19764883


  166. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn JA. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. 2009. PMID: 19521248


  167. Tsui JI, Vittinghoff E, Hahn JA, Evans JL, Davidson PJ, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. 2009. PMID: 19647375


  168. Said SM, Albouaini K, Herold J, Hahn J, Brucks S, Schmidt H, Schmeisser A, Prondzinsky R, Braun-Dullaeus RC. [Takotsubo syndrome from original description up to now]. 2009. PMID: 19533050


  169. Hahn JA, Wylie D, Dill J, Sanchez MS, Lloyd-Smith JO, Page-Shafer K, Getz WM. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. 2009. PMID: 20445816


  171. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. 2008. PMID: 18368610


  172. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. 2008. PMID: 18233994


  173. Das-Douglas M, Colfax G, Moss AR, Bangsberg DR, Hahn JA. Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003. 2007. PMID: 18163214


  174. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. 2007. PMID: 17980513


  175. Martinez P, Andia I, Emenyonu N, Hahn JA, Hauff E, Pepper L, Bangsberg DR. Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest Uganda. 2007. PMID: 17968651


  177. Hahn JA, Maier M, Byakika-Tusiime J, Oyugi JH, Bangsberg DR. Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda. 2007. PMID: 17537997


  178. Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E. High levels of subgenomic HCV plasma RNA in immunosilent infections. 2007. PMID: 17493654


  179. Hahn JA. Sex, drugs, and hepatitis C virus. 2007. PMID: 17471423


  180. Hahn JA, Kushel MB, Bangsberg DR, Riley E, Moss AR. BRIEF REPORT: the aging of the homeless population: fourteen-year trends in San Francisco. 2006. PMID: 16808781


  181. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Volume 33 of Issue 4. 2006. PMID: 16565643


  182. Kittikraisak W, Davidson PJ, Hahn JA, Lum PJ, Evans JL, Moss AR, Page-Shafer K.. Incarceration among young injectors in San Francisco: associations with risk for hepatitis C virus infection 2006. PMID:


  183. Kushel MB, Hahn JA, Evans JL, Bangsberg DR, Moss AR. Revolving doors: imprisonment among the homeless and marginally housed population. 2005. PMID: 16186453


  184. Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. 2005. PMID: 15961257


  185. Hahn JA, Bangsberg DR, McFarland W, Charlebois ED, Clark RA, Moss AR. HIV seroconversion among the homeless and marginally housed in San Francisco: a ten-year study. 2004. PMID: 15577419


  186. Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. 2004. PMID: 15486844


  187. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. 2004. PMID: 15061745


  188. Tulsky JP, Hahn JA, Long HL, Chambers DB, Robertson MJ, Chesney MA, Moss AR. Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. 2004. PMID: 14974750


  189. Lum PJ, Ochoa KC, Hahn JA, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. 2003. PMID: 12773355


  190. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). 2003. PMID: 12612103


  191. Shafer KP, Hahn JA, Lum PJ, Ochoa K, Graves A, Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. 2002. PMID: 12447014


  192. Davidson PJ, Ochoa KC, Hahn JA, Evans JL, Moss AR. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. 2002. PMID: 12472634


  193. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. 2002. PMID: 12447730


  194. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. 2001. PMID: 11431749


  195. Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. 2001. PMID: 11436937


  196. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless. A prospective study. 2000. PMID: 10934071


  197. Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, Moss AR. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. 2000. PMID: 10724056


  198. Seal KH, Ochoa KC, Hahn JA, Tulsky JP, Edlin BR, Moss AR. Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. 2000. PMID: 10695436


  199. Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. 1999. PMID: 10383367


  200. Moss AR, Hahn JA. Invited commentary: needle exchange--no help for hepatitis? 1999. PMID: 9927215


  201. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, Vugia DJ, Reingold AL. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. 1998. PMID: 9841601


  202. Hinton DR, Hahn JA, Weiss MH, Couldwell WT. Loss of Rb expression in an ACTH-secreting pituitary carcinoma. 1998. PMID: 9585068


  203. Yeh RW, Ponce de Leon A, Agasino CB, Hahn JA, Daley CL, Hopewell PC, Small PM. Stability of Mycobacterium tuberculosis DNA genotypes. 1998. PMID: 9534994


  204. Daley CL, Hahn JA, Moss AR, Hopewell PC, Schecter GF. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. 1998. PMID: 9445273


  207. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. 1996. PMID: 8938155


  208. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. 1996. PMID: 8903372


  209. Leiser RJ, Mitchell TF, Hahn JA, Abrams DI. The role of critical care nurses in euthanasia and assisted suicide. 1996. PMID: 8786782


  210. Burack JH, Cohen MR, Hahn JA, Abrams DI. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms. 1996. PMID: 8673548


  211. Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. 1996. PMID: 9346639


  212. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. 1996. PMID: 8546549


  213. Hahn JA, Zolopa AR, Moss AR, Trachtenberg AL. Tuberculosis transmission in methadone maintenance programs. 1995. PMID: 7715037


  215. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. 1995. PMID: 7698582


  217. Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, Pilote L, Moss AR. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. 1994. PMID: 8040981


  218. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Drucker E, Bloom BR. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. 1994. PMID: 7993412


  220. Schulman J, Hahn JA. Quality control of birth defect registry data: a case study. 1993. PMID: 8434104